February 8, 2022
Ebola vaccine being used in Congo produces lasting antibody response, study finds
UCLA-led study, led by Dr. Nicole A. Hoff and Dr. Anne Rimoin, finds crucial evidence that antibody response and persistence after Ebola vaccination is robust, significantly informing the use of vaccination for outbreak control.
Source:
Second Source
Source:
UCLA Newsroom